Showing results (41-50 of 469) with videos related to
Sort By:
Pageof 47
Archives of Internal Medicine|June 1, 1989
Long-term immunogenicity of a plasma-derived hepatitis B vaccine in HIV seropositive and HIV seronegative hemophiliacsP M Mannucci, A R Zanetti, A Gringeri, et al.Thrombosis and Haemostasis|August 2, 1993
Pharmacokinetics of monoclonally-purified and recombinant factor VIII in patients with severe von Willebrand diseaseM Morfini, P M Mannucci, P M Tenconi, et al.Bone Marrow Transplantation|September 1, 1991
Early haemostatic modifications following cryopreserved graft infusionA M Vannucchi, G Longo, A Bosi, et al.Haematologica|September 1, 1989
Clinical data and therapeutic approach in elderly patients with Hodgkin's diseaseA Bosi, P Ponticelli, C Casini, et al.Oncology Reports|June 16, 2000
Treatment of large cell lymphoma with the Fi2 regimen (doxorubicin, vincristine, cyclophosphamide, bleomycin and prednisone): 25-year experienceG Bellesi, L Rigacci, G Longo, et al.Pharmacoeconomics|April 7, 1997
Drug treatments for maintaining remission in Crohn's disease. A lifetime cost-utility analysisG Trallori, A MessoriAnti-Cancer Drugs|January 16, 1999
Pharmacoeconomic profile of taxanes in advanced ovarian cancerA Messori, S TrippoliOncology Reports|July 30, 1999
A new method for expressing survival and life expectancy in lifetime cost-effectiveness studies that evaluate cancer patients (review)A Messori, S TrippoliComputer Methods and Programs in Biomedicine|August 1, 1993
Meta-analysis of clinical trials based on censored end-points: simplified theory and implementation of the statistical algorithms on a microcomputerA Messori, R RampazzoEuropean Review for Medical and Pharmacological Sciences|July 20, 2022
Treatments for relapsed-refractory diffuse large B-cell lymphoma: comparison of overall survival outcomes observed with four novel agentsA Messori, E CaccesePageof 47